Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Teleheath tDCS Approach to Decrease Cannabis Use: Towards Reducing Multiple Sclerosis Disability

NCT05005013 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT05005013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05005013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Teleheath tDCS Approach to Decrease Cannabis Use: Towards Reducing Multiple Sclerosis Disability
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
September 13, 2022
Completion date
May 22, 2024
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use disorder, multiple sclerosis